deltatrials
Completed PHASE4 NCT02014428

Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis

Sponsor: AGUNCO Obstetrics and Gynecology Centre

Conditions Atrophic Vaginitis
Interventions Hyaluronic acid Placebo
Updated 5 times since 2017 Last updated: Dec 12, 2013 Primary completion: Apr 30, 2013

This PHASE4 trial investigates Atrophic Vaginitis and is currently completed. AGUNCO Obstetrics and Gynecology Centre leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AGUNCO Obstetrics and Gynecology Centre
Data source: AGUNCO Obstetrics and Gynecology Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Messina, Italy